Thursday, September 22, 2022

TPG Capital to invest in ClaimsXten if bought from UnitedHealth Group

https://ift.tt/cXCz9e2


If ClaimsXten changes hands as part of UnitedHealth Group’s proposed $13 billion acquisition of Change Healthcare, there’s already a CEO waiting in the wings and a research and development budget ready to be doubled.

Private equity group TPG Capital agreed in April to buy the claims editing software business from UnitedHealth Group for $2.2 billion. The deal is dependent on UnitedHealth’s deal for Change Healthcare surviving an antitrust challenge from the Justice Department. On Monday, federal judge Carl Nichols denied the agency’s attempt to block UnitedHealth’s purchase of Change Healthcare and ordered UnitedHealth to divest ClaimsXten, now owned by Change Healthcare, to the private equity group. 

“The divestiture will restore the competitive intensity lost because of the acquisition,” Nichols wrote in a memorandum opinion, which was unsealed Wednesday. 

UnitedHealth can finalize its acquisition of Change Healthcare as soon as 10 days after receiving the judge’s order. The Justice Department said it is considering appealing Nichols’ decision. The agency has 60 days to submit an appeal. 

If the deal is finalized, TPG Capital plans to name Carolyn Wukitch CEO of ClaimsXten, according to the memorandum opinion said. Wukitch currently serves as senior vice president and general manager for network and finance management at Change Healthcare. Wukitch and around 375 Change Healthcare employees will join TPG and continue working with ClaimsXten as part of the divestiture, according to the court document. The management team will run the business’ day-to-day operations.

Change Healthcare had 14,000 employees as of March 30, according to its annual report with the Securities and Exchange Commission. The company will be incorporated into UnitedHealth’s OptumInsight revenue cycle management arm. Once the transaction closes, Change Healthcare president and CEO Neil de Crescenzo IV will serve as CEO of OptumInsight. 

TPG Capital also plans to increase ClaimsXten’s research and development budget to $30 million by 2026, from $14 million in fiscal 2022, the opinion said. 

“Our belief is we’ll be able to invest more in the product, make it better for customers and accelerate our revenues as a result,” TPG Capital co-managing partner Nehal Raj testified during the trial. 

Change Healthcare, UnitedHealth Group and TPG Capital did not immediately respond to interview requests. 



Source link



source https://financetin.com/tpg-capital-to-invest-in-claimsxten-if-bought-from-unitedhealth-group/financetin.com

Related Posts:

  • 6 Fitness Watches to Enhance Any WorkoutIt’s not easy to stay motivated when training alone. But apathy is where the right watch can help keep you on track. Where old-school watches simply told the time and occasionally offered a stopwatch feature, today’s fitness … Read More
  • Indoor Surf Pool Makes a Splash in New Jersey's American Dream MallThis article originally appeared on Surfer.com and was republished with permission. New York and New Jersey have a reputation. Actually, we have a couple of reputations. And one of them is honesty. Brutal honesty. Granted the… Read More
  • Wall Slide This is the wall slide. The post Wall Slide appeared first on Under Armour. from Under Armour https://ift.tt/3me15Tr https://ift.tt/3jmW1KH via IFTTT … Read More
  • Reducing Sugar Consumption Do you have any tips on reducing sugar consumption? The post Reducing Sugar Consumption appeared first on Under Armour. from Under Armour https://ift.tt/3meziCa https://ift.tt/3m3mDSs via IFTTT … Read More
  • How a Bacterium Can Spread Abnormal Cell GrowthThe diagnosis of cancer can trigger strong emotions of fear, anger, anxiety and sadness.1 The National Cancer Institute estimates 606,520 people will die from cancer in 2020, or 1,661 people each day.2 They also estimate ther… Read More

0 comments:

Post a Comment